About
Joshua Hislop is a biotech and computational biology operator best known as a co-founder of HexemBio, where company materials describe him as AI Lead and SOSV lists him as CTO. HexemBio says he was first author on the foundational Nature paper behind the company's platform. Nature Communications also lists him with University of Pittsburgh affiliations and discloses that he and Mo R. Ebrahimkhani are co-founders of HexemBio with equity interests in the company.
Areas of interest
longevitybiotechartificial intelligencecomputational biologydevelopmental biologystem cellshematopoiesisregenerative medicinecell therapysynthetic biology